Proteomics International Laboratories Ltd (ASX:PIQ) has disclosed the results of its Annual General Meeting held on 20 November 2026, with six of ten resolutions failing to pass and Aaron Brinkworth appointed as Chair in the intervening period following the meeting outcomes.
Key Points
- Six resolutions were not carried at the AGM, including the re-election of Dr James Williams, approval of sign-on rights for CEO David Morris, FY27 LTI performance rights for David Morris, the additional 10% placement capacity, and the two SPP options resolutions for unrelated participants and related parties.
- Aaron Brinkworth has been appointed Chair following the AGM results.
- Resolution 3 (re-election of Paul House as director) and Resolution 4 (director shares in lieu of cash STI for David Morris) were carried.
- The Board is reviewing its position in relation to the SPP Options and will announce any variation to the terms of the SPP to shareholders prior to the Closing Date.
AGM Voting Outcomes Across Ten Resolutions
The AGM, held on 20 November 2026, considered ten resolutions by poll. The non-binding resolution to adopt the remuneration report recorded 51.85% in favour and 48.15% against on a poll basis. The re-election of Dr James Williams as director was not carried, with 61.03% of votes cast against. The re-election of Paul House was carried with 61.49% in favour. The approval to issue director shares in lieu of cash short-term incentive to CEO David Morris was carried with 92.77% support on a poll basis.
Failed Resolutions Including Placement Capacity and SPP Options
Four further resolutions were not carried at the meeting. The approval to issue sign-on rights to David Morris failed, with 67.14% of poll votes cast against. The approval of FY27 LTI director performance rights for David Morris was not carried, with 65.17% against. The approval of an additional 10% placement capacity failed, with 62.44% voting against. Resolutions 8, 9, and 10 relating to the issue of attaching SPP options to unrelated SPP participants, Aaron Brinkworth, and Paul House respectively were each not carried, with votes against ranging from 61.14% to 62.83%.
Board Review and Chair Appointment Following Meeting
Following the AGM results, the Board disclosed it is undertaking a review of the outcomes of the resolutions. In the intervening period, Aaron Brinkworth has been appointed Chair of the company. The Board also stated it is considering its position in relation to the SPP Options. According to the filing, any variation to the terms of the SPP will be announced to shareholders prior to the Closing Date of the SPP. No further details regarding the timeline of the Board review or the SPP Closing Date were disclosed in the filing.




Please wait processing your request...